(Q33790925)

29 July 2017

title

High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN). (English)

1 reference

Intraductal papillary mucinous neoplasm

29 July 2017

main subject

1 reference

1 reference

5

Gideon Rechavi

1 reference

29 July 2017

Nir Lubezky

1

1 reference

29 July 2017

Menahem Ben-Haim

2

1 reference

29 July 2017

Sylvia Marmor

3

1 reference

29 July 2017

Eli Brazowsky

4

1 reference

29 July 2017

Joseph M Klausner

6

1 reference

29 July 2017

Yoram Cohen

7

1 reference

29 July 2017

publication date

12 January 2011

1 reference

Journal of Gastrointestinal Surgery

29 July 2017

published in

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

503-511

1 reference

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Mutations of PIK3CA in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

PIK3CA mutations in advanced ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-010-1411-8

Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?

21 January 2018

1 reference

12 December 2020

High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas

1 reference

12 December 2020

Purification of DNA from formaldehyde fixed and paraffin embedded human tissue

1 reference

12 December 2020

K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas

1 reference

12 December 2020

Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.

1 reference

12 December 2020

High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations

1 reference

12 December 2020

1 reference

12 December 2020

The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasm of the pancreas

1 reference

12 December 2020

Ki-ras oncogene activation in preinvasive pancreatic cancer

1 reference

12 December 2020

Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia

1 reference

12 December 2020

The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.

1 reference

12 December 2020

Clinical presentation can predict disease course in patients with intraductal papillary mucinous neoplasm of the pancreas

1 reference

12 December 2020

K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

1 reference

12 December 2020

10.1007/S11605-010-1411-8

Identifiers

DOI

1 reference

29 July 2017

1 reference